Elexacaftor-tezacaftor-ivacaftor (ETI) treatment improves Lung Clearance Index (LCI) in patients with Cystic Fibrosis (CF) independently from baseline respiratory function

Autor:	F Lucca, S Volpi, R Guarise, A Borruso, M Signorini, M Cipolli
Rok vydání:	2022
Zdroj:	07.03 - Paediatric cystic fibrosis (CF).
DOI:	10.1183/13993003.congress-2022.3888
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::35ff2c90281ad31350b7aa4b6824aefb https://doi.org/10.1183/13993003.congress-2022.3888 Zobrazit plný text záznamu